2-cyanoacetamide
used in fluorimetric labeling of monosaccharides; structure
Also Known As:
cyanoacetamide
Networked: 3
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
| 1. | Babu, Zinka Raveendra:
1 article
(01/2018)
|
| 2. | Basha, Shaik Jeelan:
1 article
(01/2018)
|
| 3. | Damu, Amooru Gangaiah:
1 article
(01/2018)
|
| 4. | Kumar, Palaka Bhagath:
1 article
(01/2018)
|
| 5. | Mohan, Penumala:
1 article
(01/2018)
|
| 6. | Rao, Ampasala Dinakara:
1 article
(01/2018)
|
| 7. | Subramanyam, Rajagopal:
1 article
(01/2018)
|
| 8. | Yeggoni, Daniel Pushparaju:
1 article
(01/2018)
|
| 9. | Abdelhamid, Ismail A:
1 article
(01/2017)
|
| 10. | Attia, Yasmin M:
1 article
(01/2017)
|
Related Diseases
| 1. | Neoplasms (Cancer)
|
| 2. | Alzheimer Disease (Alzheimer's Disease)
01/01/2018
- " In line with the modern multi-target-directed ligand paradigm of Alzheimer's disease (AD), a series of 19 compounds composed of flavone and cyanoacetamide groups have been synthesized and evaluated as multifunctional agents against AD. " 01/01/2018
- " New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase." 12/01/2023
- " In view of Multi-Target Directed Ligand (MTDL) approach in treating Alzheimer's Disease (AD), a series of novel quinazolinone and vanillin cyanoacetamide based acrylamide derivatives (9a-z) were designed, synthesized, and assessed for their activity against a panel of selected AD targets including acetylcholinesterase (AChE), butyrylcholinesterase (BChE), amyloid β protein (Aβ), and also 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging and neuroprotective activities. "
|
|
Related Drugs and Biologics